Impact of a ward based clinical pharmacist on improving the quality use of medicines in patients with chronic non communicable diseases, compared to standard practice in a Sri Lankan teaching hospital
Not Applicable
- Conditions
- Chronic non communicable diseases
Recruitment & Eligibility
- Status
- Complete: follow up complete
- Sex
- Not specified
- Target Recruitment
- 800
Inclusion Criteria
• Patients admitted to the professorial medical unit in CNTH
• Age over 12 years
• Able to communicate in Sinhala or English
• Diagnosed with, a non communicable chronic disease (cardiovascular diseases, diabetes mellitus, pneumonia, cirrhosis, bronchial asthma and chronic obstructive pulmonary disease, chronic kidney diseases, peptic ulcer disease).
Exclusion Criteria
None
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The impact of clinical pharmacist’s service on the safety, efficacy and appropriateness of all prescribed medicines for individual patients [ using Medication Appropriateness Index - MAI ] <br> [During the hospital stay]<br>The impact of clinical pharmacist’s service on patients’ adherence to the drug regimen (compliance) is assessed by using a structured questionnaire at the 6th day of discharge through over the phone [6 days post discharge]<br>The impact of clinical pharmacist’s service on patient knowledge and understanding of their medication regimen in the post discharge period is assessed through over the phone by using a structured questionnaire [6 days post discharge]<br>
- Secondary Outcome Measures
Name Time Method Reduction in adverse drug reactions occurring during hospital stay by active surveillance and ADR reporting by the clinical pharmacist [During hospital stay]<br>